12.03.2025 – 12:11GEA Group Aktiengesellschaft2GEA presents the kytero® 10, the world's smallest single use disk stack centrifugeClick here for the GEA media pagemehr
20.02.2025 – 17:05Helmholtz MunichNew Knowledge Portal Adiposetissue.org Enhances Obesity and Metabolism Research with Centralized DataVisit https://www.adiposetissue.org/mehr
14.01.2025 – 12:00LTS Lohmann Therapie-Systeme AGLTS wins funding from BARDA’s Patch Forward Prize Competition for two partnershipsmehr
14.01.2025 – 11:15Helmholtz MunichSCP-Nano: A New Technology to Visualize Nanocarriers in Cells and Tissuesmehr
19.12.2024 – 11:43RHEACELL GmbH und Co. KGRHEACELL receives EMA approval for allo-APZ2-CVU Phase 3 trial in chronic venous ulcersmehr
11.12.2024 – 14:03Helmholtz MunichMaria-Elena Torres-Padilla Honored With the Leibniz Prize 2025Read Interviewmehr
25.11.2024 – 13:52Helmholtz MunichInceptor Regulates Insulin Homeostasis: A New Approach for Diabetes Therapiesmehr
24.09.2024 – 12:25RHEACELL GmbH und Co. KGRHEACELL announces FDA approval for Phase 3 study in refractory, non-curable CVUmehr
05.06.2024 – 17:10Helmholtz MunichNew Study: Father's Diet Before Conception Influences Children's HealthNewsroommehr
02.04.2024 – 11:10Helmholtz MunichScientists Reveal Adipocyte's Metabolic Role and Identify Treatment Targetsmehr
13.03.2024 – 16:21FDX Fluid Dynamix GmbH4FDX Fluid Dynamix and Fraunhofer IPK to Collaborate with Lonza on Novel Nanoparticle Formulation Technology Platform FDmiXmehr
28.02.2024 – 15:00RHEACELL GmbH und Co. KGResearch Success in Rare Disease / RHEACELL receives positive signal for accelerated stem cell development program in rare ‚Butterfly Disease‘mehr
28.02.2024 – 11:07Helmholtz MunichRising Focus on 'Inceptor' as a Type 2 Diabetes Therapeutic Targetmehr
19.02.2024 – 17:05Helmholtz MunichWhat Our Genetic Information Tells Us About Type 2 Diabetes Risk and ComplicationsLearn more about research at Helmholtz Munichmehr
01.02.2024 – 10:02Sysmex Europe SEStrengthening the Direct Sales and Service System for Business Expansion in ItalyVisit our website!Ein Dokumentmehr
26.01.2024 – 13:50Biomay AGBiomay Announces its Successful Support of Approval of First CRISPR/Cas9-based Therapymehr
23.11.2023 – 20:15Fraunhofer-Institut für Produktionstechnologie IPTPooling expertise: Fraunhofer IPT and Harro Höfliger cooperate in the manufacturing of ATMP production systemsPress release and imagesmehr
13.11.2023 – 13:38Biomay AGBiomay Announces Expansion of GMP-Facilities to Offer mRNA Manufacturing and Aseptic Filling Servicesmehr
05.07.2023 – 17:15Helmholtz MunichPotentiating Cancer Vulnerability to Ferroptosis: Off-Targeting Effects of DHODH Inhibitorsmehr
30.06.2023 – 10:09ARTTIC Innovation GmbH2CARAMBA: New Hope for Multiple Myeloma PatientsCARAMBA project websitemehr
28.06.2023 – 17:13Helmholtz MunichNew Approach in Cancer Therapy With Innovative Mechanism-of-Action for Ferroptosis Inductionmehr
27.06.2023 – 11:23RHEACELL GmbH und Co. KGRHEACELL announces “First Patient In”: EB-Haus in Salzburg, Austria starts pivotal study for stem cell therapy for severe forms of Epidermolysis bullosa that is longed for by those affectedmehr
22.06.2023 – 12:05ARTTIC Innovation GmbH2Study Reveals Influence of Urban Environment on Mental HealthSee Publicationmehr
08.05.2023 – 09:00Lysando AGAmicogen and Lysando: Novel approach for the treatment of mastitis in dairy cowsmehr